Vivos Therapeutics said on Wednesday the US health regulator has cleared its oral device for severe obstructive sleep apnea, leading a massive rally in the company s shares before the bell.
Restricted sleep of around 6 hours per night may be enough of a reduction to increase the risk for impaired insulin sensitivity in women, particularly if they are postmenopausal, suggests a US trial.
Philips said on Thursday it has reached a settlement to resolve one category of legal claims against it following a major recall of its sleep apnea and respiratory devices.
Sleeping 3 or more hours over or under the average sleep duration of 8 hours increases the risk for type 2 diabetes, regardless of other factors, indicates Dutch study analysis.